In contrast, few preclinical studies have linked PCSK9 to prostate cancer [65,66], although Gan and colleagues previously demonstrated that PCSK9 siRNA protects human prostate cancer cells from ionising radiation-induced cell damage [67]. Here, PCSK9 is linked to prostate carcinoma.